Renaissance Technologies
TLC

Renaissance Technologies’s Taiwan Liposome Company, Ltd. American Depository Shares TLC Stock Holding History

Renaissance Technologies’s Portfolio TLC Stock Details TLC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-11,900
Closed -$71K – 4018
2021
Q2 		$71K Sell
11,900
-8,700
-42% -$49.9K ﹤0.01% 3380
2021
Q1 		$125K Buy
20,600
+5,200
+34% +$27.3K ﹤0.01% 3207
2020
Q4 		$68K Buy
+15,400
New +$69.4K ﹤0.01% 3299

Renaissance Technologies's TLC Position: Q3 2021 in Review

Renaissance Technologies sold out of Taiwan Liposome Company, Ltd. American Depository Shares (TLC) in Q3 2021, closing a stake of 11,900 shares — an estimated $71K sold.

Renaissance Technologies first reported a position in TLC in Q4 2020 and held it in 3 quarters. The position peaked at $125K in Q1 2021. 0 funds tracked by Wall St. Rank hold TLC as of Q3 2021.

  • Renaissance Technologies reported no remaining Taiwan Liposome Company, Ltd. American Depository Shares position as of Q3 2021 after selling out during the quarter.
  • Renaissance Technologies sold 11,900 Taiwan Liposome Company, Ltd. American Depository Shares shares in Q3 2021, an estimated $71K.
  • Renaissance Technologies first reported a position in Taiwan Liposome Company, Ltd. American Depository Shares in Q4 2020 and held it in 3 quarters.
  • Renaissance Technologies's Taiwan Liposome Company, Ltd. American Depository Shares position peaked at $125K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Taiwan Liposome Company, Ltd. American Depository Shares as of Q3 2021.

Based on Renaissance Technologies's 13F filing for Q3 2021, filed 12 Nov 2021.